One case of rectal cancer metastasizing to the prostate 7 years after radical operation
-
摘要: 探讨直肠癌术后转移至前列腺的临床表现、诊断及治疗，以提高医师对此认识。南京医科大学附属逸夫医院2020年5月5日收治1例直肠癌前列腺转移男性病例，对相关文献进行复习。结合直肠腺癌病史、前列腺及病变组织切片及免疫组织化学染色病理确诊为直肠腺癌前列腺转移。对于有结直肠癌病史特别是结直肠癌临床分期较高、淋巴结转移或血管侵犯等风险因素的患者，应密切关注并定期进行检查。若患者出现排尿困难、尿频、尿急或血尿等与前列腺相关的症状，应警惕结直肠癌前列腺转移可能，及时进行评估和进一步检查，完善病理或影像学检查明确诊断，避免误诊误治并根据患者的病情选择个体化的治疗方案，结合化疗、免疫治疗、靶向治疗、局部放疗或手术。Abstract: The clinical manifestations, diagnosis, and treatment of postoperative metastasis of rectal cancer to the prostate were explored in order to enhance surgeons' understanding of this disease. A male case of rectal cancer with prostate metastasis was admitted to Sir Run Run Hospital of Nanjing Medical University on May 5th, 2020, then we reviewed relevant literature. Combined with the history of rectal adenocarcinoma, prostate and lesion tissue sections, and immunohistochemical staining pathology, he was confirmed as rectal adenocarcinoma with prostate metastasis. For patients with a history of colorectal cancer, especially those with risk factors such as high clinical stage of colorectal cancer, lymph node metastasis, or vascular invasion, close attention should be paid to and regular inspections should be performed. If the patient has symptoms related to the prostate, such as dysuria, frequent urination, urgency or hematuria, he should be alert to the possibility of prostate metastasis from colorectal cancer and conducted with timely assessment and further examination. Also, the pathological or imaging examination should be completed to confirm the diagnosis and avoid misdiagnosis and mistreatment. An individualized treatment plan was chosen according to the patient's condition, including chemotherapy, immunotherapy, targeted therapy, local radiotherapy or surgery.
-
Key words:
- prostate /
- rectal carcinoma /
- metastasis
-
-
[1] Wang CK, Chevalier D, Saluja J, et al. Regorafenib and nivolumab or pembrolizumab combination and circulating tumor DNA response assessment in refractory microsatellite stable colorectal cancer[J]. Oncologist, 2020, 25(8): e1188-e1194. doi: 10.1634/theoncologist.2020-0161
[2] Fukuoka S, Hara H, Takahashi N, et al. Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)[J]. J Clin Oncol, 2020, 38(18): 2053-2061. doi: 10.1200/JCO.19.03296
[3] 田艳涛, 康文哲. 全球癌症发病情况研究新进展[J]. 中国医药, 2021, 16(10): 1446-1447. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYG202110002.htm
[4] Osunkoya AO, Netto GJ, Epstein JI. Colorectal adenocarcinoma involving the prostate: report of 9 cases[J]. Hum Pathol, 2007, 38(12): 1836-1841. doi: 10.1016/j.humpath.2007.04.021
[5] Pesl M, Safarík L, Dusková J, et al. A case of a patient with solitary prostate metastasis of the colorectal carcinoma three years after abdominoperineal amputation of the rectum[J]. Rozhl Chir, 2004, 83(7): 333-336.
[6] Gupta T, Laskar SG, Thakur M, et al. Isolated prostatic metastasis from primary sigmoid colon carcinoma[J]. Indian J Gastroenterol, 2004, 23(3): 114-115.
[7] Youssef FR, Hunt L, Meiring PD, et al. Metastasis of a cecal adenocarcinoma to the prostate five years after a right hemicolectomy: a case report[J]. J Med Case Rep, 2011, 5: 223. doi: 10.1186/1752-1947-5-223
[8] Schips L, Zigeuner RE, Langner C, et al. Metastasis of an ascending colon carcinoma in the prostate 10 years after hemicolectomy[J]. J Urol, 2002, 168(2): 641-642. doi: 10.1016/S0022-5347(05)64701-5
[9] Kang A, Lee JH, Lin E, et al. Metastatic colon carcinoma to the prostate gland[J]. J Comput Assist Tomogr, 2013, 37(3): 463-465. doi: 10.1097/RCT.0b013e3182898248
[10] Berman JR, Nunnemann RG, Broshears JR, et al. Sigmoid colon carcinoma metastatic to prostate[J]. Urology, 1993, 41(2): 150-152. doi: 10.1016/0090-4295(93)90169-B
[11] Zhu WS, Wu JM, Wu LX, et al. Ascending colon cecal junction carcinoma with prostate metastasis: a case report and literature review[J]. Medicine, 2023, 102(11): e33308. doi: 10.1097/MD.0000000000033308
[12] Osunkoya AO. Mucinous and secondary tumors of the prostate[J]. Mod Pathol, 2018, 31(S1): S80-S95.
[13] 谢莉, 李志平. 肺腺癌前列腺转移一例报告[J]. 中国肺癌杂志, 2003, 6(3): 222. https://www.cnki.com.cn/Article/CJFDTOTAL-FAIZ200303022.htm
[14] 陈劲果, 王仕钦, 朱礼乐, 等. 前列腺转移性恶性黑色素瘤1例报告[J]. 现代泌尿外科杂志, 2023, 28(1): 91-92. https://www.cnki.com.cn/Article/CJFDTOTAL-MNWK202301014.htm
[15] Choi HB, Pyo JS, Son S, et al. Diagnostic and prognostic roles of CDX2 immunohistochemical expression in colorectal cancers[J]. Diagnostics, 2022, 12(3): 757. doi: 10.3390/diagnostics12030757
[16] Liu YF, Shu X, Qiao XF, et al. Radiomics-based machine learning models for predicting P504 s/P63 immunohistochemical expression: a noninvasive diagnostic tool for prostate cancer[J]. Front Oncol, 2022, 12: 911426. doi: 10.3389/fonc.2022.911426
[17] Quintanilha JCF, Graf RP, Fisher VA, et al. Comparative effectiveness of immune checkpoint inhibitors vs chemotherapy in patients with metastatic colorectal cancer with measures of microsatellite instability, mismatch repair, or tumor mutational burden[J]. JAMA Netw Open, 2023, 6(1): e2252244. doi: 10.1001/jamanetworkopen.2022.52244
[18] Massaut E, Bohlok A, Lucidi V, et al. The concept of oligometastases in colorectal cancer: from the clinical evidences to new therapeutic strategies[J]. Curr Opin Oncol, 2018, 30(4): 262-268. doi: 10.1097/CCO.0000000000000453
[19] Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, et al. MRI of rectal cancer: tumor staging, imaging techniques, and management[J]. Radiographics, 2019, 39(2): 367-387. doi: 10.1148/rg.2019180114
-
下载:
图(2)
计量
- 文章访问数: 466
- PDF下载数: 108
- 施引文献: 0